Published in Proc Natl Acad Sci U S A on August 18, 2015
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nat Genet (2017) 2.42
From melanocytes to melanomas. Nat Rev Cancer (2016) 0.85
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells. JCI Insight (2016) 0.78
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. Oncotarget (2016) 0.78
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies. Br J Cancer (2016) 0.76
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom Med (2017) 0.75
Untangling the genetics from the epigenetics in pancreatic cancer metastasis. Nat Genet (2017) 0.75
The evolution of tumour phylogenetics: principles and practice. Nat Rev Genet (2017) 0.75
Intratumor and Intertumor Heterogeneity in Melanoma. Transl Oncol (2017) 0.75
Epigenetic determinants of metastasis. Mol Oncol (2016) 0.75
Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System. Front Oncol (2017) 0.75
Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes. Oncoimmunology (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res (2008) 157.44
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13
Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med (2006) 15.64
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
A landscape of driver mutations in melanoma. Cell (2012) 12.61
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
The life history of 21 breast cancers. Cell (2012) 10.59
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (1997) 8.99
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol (2011) 8.37
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03
SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics (2011) 5.62
Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics (2012) 5.04
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell (2014) 4.44
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov (2013) 4.39
Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell (2008) 3.95
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov (2013) 3.71
Is cancer a disease of self-seeding? Nat Med (2006) 3.19
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. Br J Dermatol (2012) 2.31
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell (2011) 2.17
The orderly progression of melanoma nodal metastases. Ann Surg (1994) 2.16
Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer (2012) 2.02
Integrative genome comparison of primary and metastatic melanomas. PLoS One (2010) 1.97
Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res (2011) 1.90
Clinical implications of cancer self-seeding. Nat Rev Clin Oncol (2011) 1.77
Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res (2004) 1.29
Late recurrence in melanoma: clinical implications of lost dormancy. J Am Coll Surg (2013) 1.18
Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene (2012) 1.18
Isolation and molecular characterization of circulating melanoma cells. Cell Rep (2014) 1.02